M&A

Blue Cross and Blue Shield of Louisiana's sale to Elevance Health for $2.5 billion is temporarily on hold, nola.com reported Sept. 25.

Blue Cross and Blue Shield of Louisiana officials said they are again seeking to delay a regulatory hearing over its proposed sale to Elevance Health, nola.com reported Sept. 21. 

In an overwhelming majority, Amedisys shareholders approved a $3.3 billion acquisition by UnitedHealth Group's Optum on Sept. 8.

Molina Healthcare has completed the acquisition of My Choice Wisconsin, a Medicaid MCO with 44,000 members. 

Centene is reportedly offloading its last U.K. businesses, continuing a strategy under CEO Sarah London of divesting from non-core businesses. 

Centene is planning to sell its Operose clinics in the U.K., its last remaining business in the country, the Financial Times reported Aug. 30. 

From Centene signing an agreement to sell Circle Health Group, to the Justice Department scrutinizing UnitedHealth Group's proposed acquisition of Amedisys, here are eight payer merger and acquisition updates Becker's has reported since June 22:     

Managed healthcare and health insurance company Centene signed an agreement to sell Circle Health Group, an operator of 53 U.K. hospitals, for $1.2 billion.

Three payer acquisition deals have come under scrutiny by state or federal officials in August: 

Public hearings on Elevance Health's proposed acquisition of Blue Cross Blue Shield of Louisiana have been postponed after state officials raised concerns about the sale.